G.S. Murkitt

502 total citations
16 papers, 292 citations indexed

About

G.S. Murkitt is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, G.S. Murkitt has authored 16 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in G.S. Murkitt's work include Receptor Mechanisms and Signaling (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Analytical Chemistry and Chromatography (3 papers). G.S. Murkitt is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Analytical Chemistry and Chromatography (3 papers). G.S. Murkitt collaborates with scholars based in United Kingdom and Canada. G.S. Murkitt's co-authors include R.D. McDowall, Valentina Picot, E. Doyle, Jeannette M. Watson, Lee A. Dawson, Paul W. Smith, Jim J. Hagan, Zining Wu, Antonio Vong and Gareth Jones and has published in prestigious journals such as Journal of Chromatography A, Neuropsychopharmacology and European Journal of Pharmacology.

In The Last Decade

G.S. Murkitt

16 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.S. Murkitt United Kingdom 9 109 85 84 56 47 16 292
L. Treiber United States 12 94 0.9× 109 1.3× 68 0.8× 21 0.4× 22 0.5× 38 357
Antonio Triolo Italy 13 155 1.4× 227 2.7× 49 0.6× 41 0.7× 76 1.6× 35 406
Tadakazu Tokumura Japan 14 95 0.9× 122 1.4× 83 1.0× 29 0.5× 30 0.6× 42 442
Bruce A. Lodge Canada 9 142 1.3× 68 0.8× 106 1.3× 30 0.5× 53 1.1× 55 320
Malcolm L. Robinson United Kingdom 9 97 0.9× 82 1.0× 71 0.8× 27 0.5× 51 1.1× 23 324
Michael Chlenov United States 10 103 0.9× 85 1.0× 47 0.6× 11 0.2× 64 1.4× 21 263
Karen L Locker United Kingdom 7 91 0.8× 124 1.5× 37 0.4× 77 1.4× 59 1.3× 8 296
C. Jarry France 11 156 1.4× 91 1.1× 94 1.1× 20 0.4× 139 3.0× 43 379
Humeida A. El-Obeid Saudi Arabia 10 50 0.5× 106 1.2× 74 0.9× 22 0.4× 41 0.9× 33 279
W. J. A. Vanden Heuvel United States 9 185 1.7× 105 1.2× 65 0.8× 22 0.4× 47 1.0× 12 372

Countries citing papers authored by G.S. Murkitt

Since Specialization
Citations

This map shows the geographic impact of G.S. Murkitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.S. Murkitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.S. Murkitt more than expected).

Fields of papers citing papers by G.S. Murkitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.S. Murkitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.S. Murkitt. The network helps show where G.S. Murkitt may publish in the future.

Co-authorship network of co-authors of G.S. Murkitt

This figure shows the co-authorship network connecting the top 25 collaborators of G.S. Murkitt. A scholar is included among the top collaborators of G.S. Murkitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.S. Murkitt. G.S. Murkitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Forbes, Ian T., Steve P. Watson, Graeme I. Stevenson, et al.. (2010). The discovery of a series of N-substituted 3-(4-piperidinyl)-1,3-benzoxazolinones and oxindoles as highly brain penetrant, selective muscarinic M1 agonists. Bioorganic & Medicinal Chemistry Letters. 20(18). 5434–5438. 16 indexed citations
2.
Dawson, Lee A., Christopher J. Langmead, Jeannette M. Watson, et al.. (2009). In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics. European Journal of Pharmacology. 627(1-3). 106–114. 10 indexed citations
3.
Smith, Paul W., Paul Wyman, Peter J. Lovell, et al.. (2008). New quinoline NK3 receptor antagonists with CNS activity. Bioorganic & Medicinal Chemistry Letters. 19(3). 837–840. 45 indexed citations
4.
Dawson, Lee A., Claire M. Scott, Jeannette M. Watson, et al.. (2007). In Vitro and In Vivo Characterization of the Non-peptide NK3 Receptor Antagonist SB-223412 (Talnetant): Potential Therapeutic Utility in the Treatment of Schizophrenia. Neuropsychopharmacology. 33(7). 1642–1652. 34 indexed citations
5.
Murkitt, G.S., et al.. (1994). Fully automated assay for the determination of GR117289X in human plasma using mixed mode solid-phase extraction and high-performance liquid chromatography with ultraviolet detection. Journal of Pharmaceutical and Biomedical Analysis. 12(9). 1181–1187. 3 indexed citations
6.
Doyle, E., R.D. McDowall, G.S. Murkitt, Valentina Picot, & Sally J. Rogers. (1990). Two systems for the automated analysis of drugs in biological fluids using high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 527(1). 67–77. 14 indexed citations
7.
McDowall, R.D., E. Doyle, G.S. Murkitt, & Valentina Picot. (1989). Sample preparation for the HPLC analysis of drugs in biological fluids. Journal of Pharmaceutical and Biomedical Analysis. 7(9). 1087–1096. 46 indexed citations
8.
McDowall, R.D., et al.. (1989). Sample preparation using bonded silica: Recent experiences and new instrumentation. TrAC Trends in Analytical Chemistry. 8(4). 134–140. 20 indexed citations
9.
McDowall, R.D., et al.. (1988). Laboratory information management systems — part II. Implementation. Journal of Pharmaceutical and Biomedical Analysis. 6(4). 361–381. 5 indexed citations
10.
McDowall, R.D., et al.. (1988). The LIMS infrastructure. Chemometrics and Intelligent Laboratory Systems. 4(2). 121–129. 4 indexed citations
11.
McDowall, R.D., et al.. (1988). Laboratory information management systems — part I. Concepts. Journal of Pharmaceutical and Biomedical Analysis. 6(4). 339–359. 8 indexed citations
12.
Murkitt, G.S., et al.. (1987). Quantification of a positive inotropic agent in plasma: Towards total automation. Chromatographia. 24(1). 411–415. 5 indexed citations
13.
McDowall, R.D., et al.. (1986). Liquid—solid sample preparation in drug analysis. Journal of Pharmaceutical and Biomedical Analysis. 4(1). 3–21. 67 indexed citations
14.
Murkitt, G.S., et al.. (1986). An assay for prizidilol in plasma and urine by high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 4(1). 115–121. 1 indexed citations
15.
16.
McDowall, R.D., et al.. (1984). Improved assay procedure for oxmetidine and its metabolites in plasma, urine and bile samples. Journal of Chromatography B Biomedical Sciences and Applications. 305(1). 214–221. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026